Insider Trading & Ownership of Skorpios Trust

Location
Limassol, Cyprus
Summary
The estimated value of insider holdings of Skorpios Trust is at least $41,855,221 dollars as of 06 Jun 2025. Skorpios Trust is the 10%+ Owner of Stoke Therapeutics, Inc. and owns shares of Stoke Therapeutics, Inc. (STOK) stock worth about $39.84M. Skorpios Trust is the Former 10% owner of Akero Therapeutics, Inc. and owns shares of Akero Therapeutics, Inc. stock worth about $2.01M.
Signature
/s/ Androulla Papadopoulou, Authorized Signatory on behalf of Skorpios Trust
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Skorpios Trust and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Skorpios Trust has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $41,855,221.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Stoke Therapeutics, Inc. ($39,843,046).
  • Past-year value change for that position: -$30,600,000.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Skorpios Trust

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
STOK Stoke Therapeutics, Inc. 10%+ Owner $39,843,046 -$30,600,000 -43% 04 Jun 2025
AKRO Akero Therapeutics, Inc. Former 10% owner $2,012,175 01 Dec 2022

Insider Transactions Reported by Skorpios Trust:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .